Impact of natremia on metastatic non small cell lung cancer patients receiving immune checkpoint inhibitors

Impact of natremia on metastatic non small cell lung cancer patients receiving immune checkpoint inhibitors

Abstract Hyponatremia has been established as a prognostic indicator of survival in metastatic non-small cell lung cancer (mNSCLC). Conversely, the influence of normal sodium levels remains unexplored. This study aims to investigate the impact of natremia in mNSCLC patients undergoing treatment with...

Full description

Bibliographic Details
Main Authors: Martina Catalano, Sara Fancelli, Enrico Caliman, Francesca Mazzoni, Marta Gatta Michelet, Silvia Mancini, Clara Manneschi, Sonia Shabani, Brunella Napolitano, Serena Pillozzi, Lorenzo Antonuzzo, Giandomenico Roviello
Format: Article
Language:English
Published: Nature Portfolio 2024-11-01
Series:Scientific Reports
Subjects:
Non-small cell lung cancer
Immunotherapy
Pembrolizumab
Atezolizumab
Serum sodium
Prognostic factor
Online Access:https://doi.org/10.1038/s41598-024-81458-z

Internet

https://doi.org/10.1038/s41598-024-81458-z

Similar Items